Take the Diabetes Health Pump Survey
Diabetes Health magazine
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • Eating Well (or at Least Not terribly) at Fast Food Resturants
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
next
Latest
Popular
Top Rated

Latest Type 2 Medications Articles

Drug Combo Slows Onset of Type 2 Diabetes
Vitamin D May Reduce Risk for Type 2
Tradjenta, a Drug for Type 2s, Now on U.S. Market
Looking at Cannabis Based Type 2 Treatment
Type 2 Profile: Tony Flores
Keeping the Weight Off: An Interview with Ellen Granberg, PhD
A New Kind of Pharmacist
Need Medicine and Have No Insurance for Your Diabetes?
Flushing Away High Blood Sugar
Walgreens in South Florida and Diabetes Research Institute Foundation Announce Unique Partnership
Diabetes Health Reference Charts
Type 2 Medications (PDF)
Type 2 Meds Reference Guide (PDF)
See All Charts…
Type 2 Medications Archives
Browse the Type 2 Medications Archives
Subscribe to the Medications RSS Feed
Print | Email | Share | Comments (0)

New Pill for People with Type 2 Diabetes

Glyburide

Nov 1, 1992

This press release is an announcement submitted by Upjohn Company, and was not written by Diabetes Health.

Glyburide.

The Upjohn Company has recently released a new glyburide tablet that is designed to improve absorption and dosing flexibility for people with Type 2 diabetes.

The Glynase PresTab tablet is a patented 3 mg glyburide tablet that divides easily in two with the press of a finger. This new design allows diabetes patients to measure their prescribed daily dosage easily and accurately, with a consistent available potency between 90% and 100%.

According to the Upjohn Company, Glynase PresTab's improved potency allows patients to take a dosage lower than the already available Micronase glyburide tablet and still expect the same results. The Upjohn Company recommends that patients have their dosage readjusted by a doctor before switching from Micronase or other hypoglycemic agents to Glynase PresTab.

Categories: Diabetes, Medications, Type 2 Issues, Type 2 Medications

Donate to Diabetes Health

You May Also Be Interested In...

Click Here To View Or Post Comments

Comments 0 comments - Nov 1, 1992

©1991-2013 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.